Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 396,100 | 361,000 | 320,300 | 321,200 | 334,100 |
| Receivables | 302,500 | 303,400 | 294,000 | 278,600 | 272,100 |
| Inventories | 203,600 | 212,200 | 182,300 | 174,600 | 165,900 |
| Income taxes - deferred | 32,300 | 44,200 | 37,800 | 42,700 | 48,300 |
| Other current assets | 62,700 | 26,600 | 35,500 | 22,300 | 35,100 |
| TOTAL | $1,032,600 | $992,400 | $918,900 | $872,700 | $889,200 |
| Non-Current Assets | |||||
| PPE Net | 269,800 | 260,300 | 249,800 | 247,200 | 252,000 |
| Investments And Advances | 25,000 | 22,300 | 21,900 | 21,900 | 22,300 |
| Intangibles | 382,300 | 386,900 | 389,500 | 398,800 | 401,900 |
| Other Non-Current Assets | 57,500 | 63,500 | 61,800 | 63,800 | 50,100 |
| TOTAL | $734,600 | $733,000 | $723,000 | $731,700 | $726,300 |
| Total Assets | $1,767,200 | $1,725,400 | $1,641,900 | $1,604,400 | $1,615,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 41,800 | 100,600 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 47,600 | 281,600 | 247,700 | 242,200 | 51,100 |
| Accrued Expenses | 226,100 | N/A | N/A | N/A | 203,500 |
| TOTAL | $337,800 | $382,200 | $247,700 | $242,200 | $290,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 177,500 | 129,300 | 90,300 |
| Other Non-Current Liabilities | 121,200 | 109,700 | 98,900 | 81,400 | 76,800 |
| TOTAL | $121,200 | $109,700 | $276,400 | $210,700 | $167,100 |
| Total Liabilities | $459,000 | $491,900 | $524,100 | $452,900 | $457,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 689,104 | 685,072 | 680,103 | 679,876 | 678,707 |
| Common Shares | 117,000 | 116,100 | 115,100 | 77,200 | 76,100 |
| Retained earnings | 1,124,000 | 1,059,200 | 1,011,200 | 953,700 | 906,000 |
| Other shareholders' equity | -42,100 | -24,200 | -53,300 | -25,200 | -8,200 |
| TOTAL | $1,308,200 | $1,233,500 | $1,117,800 | $1,151,500 | $1,157,900 |
| Total Liabilities And Equity | $1,767,200 | $1,725,400 | $1,641,900 | $1,604,400 | $1,615,500 |